'Once a week insulin to be launched in India in 2025', says Novo Nordisk India MD Vikrant Shrotriya

What roles and opportunities does Novo Nordisk see for itself as India continues to struggle with growing burden of diabetes, obesity? Watch the company's India MD Vikrant Shrotriya , in conversation with ThePrint's Sumi Sukanya Dutta in #ThePrintInterview
---------------------------------------------------------------------------------------------
Exclusive content, special privileges & more - Subscribe to ThePrint for Special benefits: theprint.in/subscribe/
---------------------------------------------------------------------------------------------
Connect with ThePrint
» Subscribe to ThePrint: theprint.in/subscribe/
» Subscribe to our KZread Channel: bit.ly/3nCMpht
» Like us on Facebook: / theprintindia
» Tweet us on Twitter: / theprintindia
» Follow us on Instagram: / theprintindia
» Find us on LinkedIn : / theprint
» Subscribe to ThePrint on Telegram: t.me/ThePrintIndia
» Find us on Spotify: spoti.fi/2NMVlnB
» Find us on Apple Podcasts: apple.co/3pEOta8

Пікірлер: 11

  • @vivekpandey1088
    @vivekpandey108810 ай бұрын

    In recent years, it appears like lifestyle related disorders have killed more people than the natural ageing and life cycle. The same needle prick does have different impact on different individual, it's not as easy for everyone. This wealth of information coming from Vikrant Shrotria of Novo Nordisk about comforting diabetic patients from daily needles to weekly is certainly a breakthrough. The innovation and range of product pipeline to improve lifestyle conditions is a welcome development 👏

  • @State_of_palestine_2025
    @State_of_palestine_202510 ай бұрын

    Once a week Once a month Once a year Once in ten year Once in a lifetime.

  • @okletzgo4133
    @okletzgo413310 ай бұрын

    The real question is how much price would it be available for, even though there are insulin pumps and continuous monitoring meters large quantity of t1ds cannot afford it.

  • @pcmanoria7686
    @pcmanoria76863 ай бұрын

    Dr Shrotiya Great News.Heartiest congratulations for your relentless Hard work.

  • @SamirMishra6174
    @SamirMishra61746 ай бұрын

    Thanks for covering this

  • @biswajithalder8556
    @biswajithalder85563 ай бұрын

    But oral semeglutide is very costly. Decrease the rate at least 75% . Otherwise mass public cannot afford the cost.

  • @kaneater1
    @kaneater110 ай бұрын

    is it true nd can v use for type 1 my child

  • @utkarshdesai4116
    @utkarshdesai411610 ай бұрын

    What a boon it is to have oral semaglutide in India, it has been a true game changer for people living with type 2 diabetes to manage their blood sugar and weight. I personally know of people within my family that are on this drug and it has completely changed the way they feel both physically and psychologically, not to mention their diabetes is completely under control. Novo Nordisk at its best in terms of bringing such innovations and truly changing diabetes!

  • @ajanup1
    @ajanup110 ай бұрын

    Semaglutide oral easily available in urban centres.

  • @CharkhaOfficial
    @CharkhaOfficial10 ай бұрын

    Vikrant 👍

  • @JitendraSingh-ev7ml
    @JitendraSingh-ev7ml10 ай бұрын

    Best innovations available to people.